Big Phar­ma CEOs push hard for tax re­form and a pro­posed bor­der levy

Big bio­phar­ma is bull­ish on the prospects of tax re­form un­der the Trump ad­min­is­tra­tion. And it wants to get a deal done AS­AP.

In a let­ter ad­dressed by a line­up of cor­po­rate CEOs — in­clud­ing Eli Lil­ly’s David Ricks, Pfiz­er’s Ian Read, Ken Fra­zier from Mer­ck and Mark Alles at Cel­gene — the group billing it­self as the “Amer­i­can Made Coali­tion” urged lead­ers of the House and Sen­ate to ral­ly around a re­form plan that would al­low for the repa­tri­a­tion of bil­lions of dol­lars in over­seas ac­counts and a low­er tax rate for all com­pa­nies.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.